We have facilities, equipment, and instruments to develop various dosage forms including tablet, capsule, particulate, ointment, cream, gel, injectable, suspension, oral liquid, and others. In addition, we are highly skilled in developing complex dosage forms including but not limited to various control-released dosage forms, nanocrystal formulation, microemulsion, amorphous solid dispersion and others. Additionally, we have more than ten GMP suits that can manufacture drug products to support the pre-pivotal clinical studies. Our employees in drug product R&D are highly educated, experienced, and knowledgeable in pharmaceutical dosage form development. We define drug product QTPP, and CQA and then follow the QbD strategy to perform risk assessment and risk characterization, and finally provide the risk mitigation and control strategies for commercial manufacturing and launch.
We have the capability to develop but not limited to the following dosage forms
